SS-31 (Elamipretide) for Insomnia: Evidence Review
What's breaking down
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
Why SS-31 (Elamipretide) might help you
- Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.
How these fit together
Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.
- SS-31 (Elamipretide) → mitochondrial
What the evidence actually shows
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 3
- Claims tagged human evidence: 1
- Claims tagged preclinical (animal/lab): 2
- Claims tagged anecdotal: 1
- Reddit posts catalogued: 1
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 4
Quantified confidence (this ledger): 0.29 / 1.00 — low — animal and anecdote heavy
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Mitochondrial antioxidant elamipretide improves learning and memory impairment induced by chronic sleep deprivation in mice (source s1)
2024 mouse study on chronic sleep deprivation and elamipretide effects on cognition and mitochondria.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Adverse Neurological Effects of Short-Term Sleep Deprivation in Aging Mice Are Prevented by SS31 Peptide (source s2)
2020 study showing SS-31 protection against sleep deprivation neurological effects in mice.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
SS-31 (also known as Elamipretide®, Bendavia®, and MTP-131) (source s3)
Overview noting lack of insomnia-specific human data and mixed trial outcomes.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
What people say on Reddit
My Experience Treating my ME/CFS with mitochondrial peptides (SS-31) — Reddit, r/cfs (source s4)
User reports on SS-31 effects including energy and occasional sleep notes from multiple threads.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 4 · tier-ranked · API
Model review1 contributions · 1 modelExpand the recursive review layer
/api/articles/ss-31-insomnia/contributionsAsk this article · 7 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.